nodes	percent_of_prediction	percent_of_DWPC	metapath
Zaleplon—CYP3A4—Imiquimod—skin cancer	0.104	0.192	CbGbCtD
Zaleplon—CYP3A4—Temozolomide—skin cancer	0.104	0.192	CbGbCtD
Zaleplon—CYP3A4—Vismodegib—skin cancer	0.0722	0.133	CbGbCtD
Zaleplon—CYP3A7-CYP3A51P—Docetaxel—skin cancer	0.067	0.124	CbGbCtD
Zaleplon—CYP3A7—Docetaxel—skin cancer	0.067	0.124	CbGbCtD
Zaleplon—CYP3A4—Vemurafenib—skin cancer	0.0571	0.105	CbGbCtD
Zaleplon—CYP3A5—Docetaxel—skin cancer	0.0502	0.0928	CbGbCtD
Zaleplon—CYP3A4—Docetaxel—skin cancer	0.0196	0.0362	CbGbCtD
Zaleplon—TSPO—hindlimb—skin cancer	0.00504	0.136	CbGeAlD
Zaleplon—TSPO—appendage—skin cancer	0.00432	0.117	CbGeAlD
Zaleplon—TSPO—hair follicle—skin cancer	0.00257	0.0694	CbGeAlD
Zaleplon—TSPO—blood vessel—skin cancer	0.00241	0.0651	CbGeAlD
Zaleplon—AOX1—nipple—skin cancer	0.00204	0.0551	CbGeAlD
Zaleplon—TSPO—nipple—skin cancer	0.00174	0.0471	CbGeAlD
Zaleplon—TSPO—neck—skin cancer	0.00172	0.0466	CbGeAlD
Zaleplon—TSPO—connective tissue—skin cancer	0.00123	0.0334	CbGeAlD
Zaleplon—AOX1—mammalian vulva—skin cancer	0.00119	0.0322	CbGeAlD
Zaleplon—TSPO—epithelium—skin cancer	0.00117	0.0317	CbGeAlD
Zaleplon—GABRB3—connective tissue—skin cancer	0.00112	0.0303	CbGeAlD
Zaleplon—TSPO—skin of body—skin cancer	0.00111	0.0301	CbGeAlD
Zaleplon—AOX1—female reproductive system—skin cancer	0.00102	0.0276	CbGeAlD
Zaleplon—TSPO—mammalian vulva—skin cancer	0.00102	0.0275	CbGeAlD
Zaleplon—TSPO—lymphoid tissue—skin cancer	0.000902	0.0244	CbGeAlD
Zaleplon—TSPO—female reproductive system—skin cancer	0.00087	0.0235	CbGeAlD
Zaleplon—GABRB2—head—skin cancer	0.00086	0.0233	CbGeAlD
Zaleplon—GABRG2—head—skin cancer	0.00086	0.0233	CbGeAlD
Zaleplon—GABRB3—female reproductive system—skin cancer	0.00079	0.0214	CbGeAlD
Zaleplon—GABRA2—head—skin cancer	0.000785	0.0212	CbGeAlD
Zaleplon—GABRA1—head—skin cancer	0.000759	0.0205	CbGeAlD
Zaleplon—TSPO—head—skin cancer	0.000727	0.0197	CbGeAlD
Zaleplon—Weight decreased—Temozolomide—skin cancer	0.000699	0.00166	CcSEcCtD
Zaleplon—Anorexia—Imiquimod—skin cancer	0.000699	0.00166	CcSEcCtD
Zaleplon—Hyperglycaemia—Temozolomide—skin cancer	0.000697	0.00165	CcSEcCtD
Zaleplon—Angina pectoris—Fluorouracil—skin cancer	0.000694	0.00164	CcSEcCtD
Zaleplon—Pneumonia—Temozolomide—skin cancer	0.000693	0.00164	CcSEcCtD
Zaleplon—Depression—Temozolomide—skin cancer	0.000687	0.00163	CcSEcCtD
Zaleplon—Thrombophlebitis—Docetaxel—skin cancer	0.000687	0.00163	CcSEcCtD
Zaleplon—Body temperature increased—Vemurafenib—skin cancer	0.00068	0.00161	CcSEcCtD
Zaleplon—Neuropathy peripheral—Temozolomide—skin cancer	0.000675	0.0016	CcSEcCtD
Zaleplon—Swelling—Docetaxel—skin cancer	0.000674	0.0016	CcSEcCtD
Zaleplon—Stomatitis—Temozolomide—skin cancer	0.000672	0.00159	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000668	0.00158	CcSEcCtD
Zaleplon—Deafness—Docetaxel—skin cancer	0.000665	0.00158	CcSEcCtD
Zaleplon—Insomnia—Imiquimod—skin cancer	0.000663	0.00157	CcSEcCtD
Zaleplon—GABRB3—head—skin cancer	0.00066	0.0179	CbGeAlD
Zaleplon—Paraesthesia—Imiquimod—skin cancer	0.000659	0.00156	CcSEcCtD
Zaleplon—Chills—Bleomycin—skin cancer	0.000658	0.00156	CcSEcCtD
Zaleplon—Dyspnoea—Imiquimod—skin cancer	0.000654	0.00155	CcSEcCtD
Zaleplon—Somnolence—Imiquimod—skin cancer	0.000652	0.00155	CcSEcCtD
Zaleplon—Hepatobiliary disease—Temozolomide—skin cancer	0.000652	0.00155	CcSEcCtD
Zaleplon—Photosensitivity reaction—Fluorouracil—skin cancer	0.00065	0.00154	CcSEcCtD
Zaleplon—Alopecia—Bleomycin—skin cancer	0.000648	0.00154	CcSEcCtD
Zaleplon—Dyspepsia—Imiquimod—skin cancer	0.000646	0.00153	CcSEcCtD
Zaleplon—Pneumonia—Fluorouracil—skin cancer	0.000639	0.00151	CcSEcCtD
Zaleplon—Decreased appetite—Imiquimod—skin cancer	0.000638	0.00151	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Imiquimod—skin cancer	0.000633	0.0015	CcSEcCtD
Zaleplon—Pain—Imiquimod—skin cancer	0.000627	0.00149	CcSEcCtD
Zaleplon—Neuropathy peripheral—Fluorouracil—skin cancer	0.000622	0.00148	CcSEcCtD
Zaleplon—Dermatitis bullous—Docetaxel—skin cancer	0.000622	0.00148	CcSEcCtD
Zaleplon—Stomatitis—Fluorouracil—skin cancer	0.000619	0.00147	CcSEcCtD
Zaleplon—Conjunctivitis—Fluorouracil—skin cancer	0.000617	0.00146	CcSEcCtD
Zaleplon—Asthenia—Vemurafenib—skin cancer	0.000617	0.00146	CcSEcCtD
Zaleplon—Hallucination—Temozolomide—skin cancer	0.000615	0.00146	CcSEcCtD
Zaleplon—Hypoaesthesia—Temozolomide—skin cancer	0.000615	0.00146	CcSEcCtD
Zaleplon—Chills—Dactinomycin—skin cancer	0.000614	0.00146	CcSEcCtD
Zaleplon—Oedema peripheral—Temozolomide—skin cancer	0.000609	0.00144	CcSEcCtD
Zaleplon—Pruritus—Vemurafenib—skin cancer	0.000608	0.00144	CcSEcCtD
Zaleplon—Alopecia—Dactinomycin—skin cancer	0.000604	0.00143	CcSEcCtD
Zaleplon—Feeling abnormal—Imiquimod—skin cancer	0.000604	0.00143	CcSEcCtD
Zaleplon—Gastrointestinal pain—Imiquimod—skin cancer	0.0006	0.00142	CcSEcCtD
Zaleplon—Epistaxis—Fluorouracil—skin cancer	0.000599	0.00142	CcSEcCtD
Zaleplon—Visual impairment—Temozolomide—skin cancer	0.000596	0.00141	CcSEcCtD
Zaleplon—AOX1—lymph node—skin cancer	0.000596	0.0161	CbGeAlD
Zaleplon—Ill-defined disorder—Bleomycin—skin cancer	0.000592	0.0014	CcSEcCtD
Zaleplon—Anaemia—Bleomycin—skin cancer	0.00059	0.0014	CcSEcCtD
Zaleplon—Migraine—Docetaxel—skin cancer	0.000585	0.00139	CcSEcCtD
Zaleplon—Urticaria—Imiquimod—skin cancer	0.000583	0.00138	CcSEcCtD
Zaleplon—Abdominal pain—Imiquimod—skin cancer	0.00058	0.00137	CcSEcCtD
Zaleplon—Body temperature increased—Imiquimod—skin cancer	0.00058	0.00137	CcSEcCtD
Zaleplon—Eye disorder—Temozolomide—skin cancer	0.000578	0.00137	CcSEcCtD
Zaleplon—Tinnitus—Temozolomide—skin cancer	0.000577	0.00137	CcSEcCtD
Zaleplon—Malaise—Bleomycin—skin cancer	0.000576	0.00137	CcSEcCtD
Zaleplon—Dizziness—Vemurafenib—skin cancer	0.000569	0.00135	CcSEcCtD
Zaleplon—Hypoaesthesia—Fluorouracil—skin cancer	0.000567	0.00134	CcSEcCtD
Zaleplon—Ataxia—Docetaxel—skin cancer	0.000559	0.00133	CcSEcCtD
Zaleplon—Immune system disorder—Temozolomide—skin cancer	0.000559	0.00132	CcSEcCtD
Zaleplon—Chills—Temozolomide—skin cancer	0.000555	0.00132	CcSEcCtD
Zaleplon—Ill-defined disorder—Dactinomycin—skin cancer	0.000552	0.00131	CcSEcCtD
Zaleplon—Anaemia—Dactinomycin—skin cancer	0.00055	0.0013	CcSEcCtD
Zaleplon—GABRA2—lymph node—skin cancer	0.00055	0.0149	CbGeAlD
Zaleplon—Liver function test abnormal—Docetaxel—skin cancer	0.000549	0.0013	CcSEcCtD
Zaleplon—Alopecia—Temozolomide—skin cancer	0.000547	0.0013	CcSEcCtD
Zaleplon—Dry skin—Docetaxel—skin cancer	0.000545	0.00129	CcSEcCtD
Zaleplon—Chest pain—Bleomycin—skin cancer	0.000543	0.00129	CcSEcCtD
Zaleplon—Myalgia—Bleomycin—skin cancer	0.000543	0.00129	CcSEcCtD
Zaleplon—Orthostatic hypotension—Docetaxel—skin cancer	0.000543	0.00129	CcSEcCtD
Zaleplon—Rash—Vemurafenib—skin cancer	0.000542	0.00129	CcSEcCtD
Zaleplon—Mental disorder—Temozolomide—skin cancer	0.000542	0.00129	CcSEcCtD
Zaleplon—Dermatitis—Vemurafenib—skin cancer	0.000542	0.00128	CcSEcCtD
Zaleplon—Headache—Vemurafenib—skin cancer	0.000539	0.00128	CcSEcCtD
Zaleplon—Malnutrition—Temozolomide—skin cancer	0.000538	0.00128	CcSEcCtD
Zaleplon—Breast disorder—Docetaxel—skin cancer	0.000537	0.00127	CcSEcCtD
Zaleplon—Discomfort—Bleomycin—skin cancer	0.000537	0.00127	CcSEcCtD
Zaleplon—Malaise—Dactinomycin—skin cancer	0.000537	0.00127	CcSEcCtD
Zaleplon—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.000535	0.00127	CcSEcCtD
Zaleplon—Dysgeusia—Temozolomide—skin cancer	0.000527	0.00125	CcSEcCtD
Zaleplon—Asthenia—Imiquimod—skin cancer	0.000526	0.00125	CcSEcCtD
Zaleplon—Confusional state—Bleomycin—skin cancer	0.000525	0.00125	CcSEcCtD
Zaleplon—Alanine aminotransferase increased—Docetaxel—skin cancer	0.000524	0.00124	CcSEcCtD
Zaleplon—Anaphylactic shock—Bleomycin—skin cancer	0.000521	0.00124	CcSEcCtD
Zaleplon—Oedema—Bleomycin—skin cancer	0.000521	0.00124	CcSEcCtD
Zaleplon—Back pain—Temozolomide—skin cancer	0.000521	0.00124	CcSEcCtD
Zaleplon—Pruritus—Imiquimod—skin cancer	0.000519	0.00123	CcSEcCtD
Zaleplon—Dysphagia—Docetaxel—skin cancer	0.000514	0.00122	CcSEcCtD
Zaleplon—Nausea—Vemurafenib—skin cancer	0.000511	0.00121	CcSEcCtD
Zaleplon—TSPO—lymph node—skin cancer	0.000509	0.0138	CbGeAlD
Zaleplon—Myalgia—Dactinomycin—skin cancer	0.000507	0.0012	CcSEcCtD
Zaleplon—Tremor—Temozolomide—skin cancer	0.000505	0.0012	CcSEcCtD
Zaleplon—Alopecia—Fluorouracil—skin cancer	0.000504	0.00119	CcSEcCtD
Zaleplon—Discomfort—Dactinomycin—skin cancer	0.000501	0.00119	CcSEcCtD
Zaleplon—Angina pectoris—Docetaxel—skin cancer	0.000501	0.00119	CcSEcCtD
Zaleplon—Ill-defined disorder—Temozolomide—skin cancer	0.0005	0.00118	CcSEcCtD
Zaleplon—Anaemia—Temozolomide—skin cancer	0.000498	0.00118	CcSEcCtD
Zaleplon—Anorexia—Bleomycin—skin cancer	0.000497	0.00118	CcSEcCtD
Zaleplon—Agitation—Temozolomide—skin cancer	0.000495	0.00117	CcSEcCtD
Zaleplon—Angioedema—Temozolomide—skin cancer	0.000492	0.00117	CcSEcCtD
Zaleplon—Hypotension—Bleomycin—skin cancer	0.000487	0.00115	CcSEcCtD
Zaleplon—Oedema—Dactinomycin—skin cancer	0.000486	0.00115	CcSEcCtD
Zaleplon—Malaise—Temozolomide—skin cancer	0.000486	0.00115	CcSEcCtD
Zaleplon—Dizziness—Imiquimod—skin cancer	0.000485	0.00115	CcSEcCtD
Zaleplon—Vertigo—Temozolomide—skin cancer	0.000484	0.00115	CcSEcCtD
Zaleplon—Palpitations—Temozolomide—skin cancer	0.000476	0.00113	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000475	0.00113	CcSEcCtD
Zaleplon—Paraesthesia—Bleomycin—skin cancer	0.000468	0.00111	CcSEcCtD
Zaleplon—Weight increased—Docetaxel—skin cancer	0.000468	0.00111	CcSEcCtD
Zaleplon—Weight decreased—Docetaxel—skin cancer	0.000465	0.0011	CcSEcCtD
Zaleplon—Hypertension—Temozolomide—skin cancer	0.000465	0.0011	CcSEcCtD
Zaleplon—Dyspnoea—Bleomycin—skin cancer	0.000464	0.0011	CcSEcCtD
Zaleplon—Anorexia—Dactinomycin—skin cancer	0.000463	0.0011	CcSEcCtD
Zaleplon—Rash—Imiquimod—skin cancer	0.000462	0.0011	CcSEcCtD
Zaleplon—Dermatitis—Imiquimod—skin cancer	0.000462	0.0011	CcSEcCtD
Zaleplon—Pneumonia—Docetaxel—skin cancer	0.000461	0.00109	CcSEcCtD
Zaleplon—Headache—Imiquimod—skin cancer	0.000459	0.00109	CcSEcCtD
Zaleplon—Anaemia—Fluorouracil—skin cancer	0.000459	0.00109	CcSEcCtD
Zaleplon—Arthralgia—Temozolomide—skin cancer	0.000458	0.00109	CcSEcCtD
Zaleplon—Myalgia—Temozolomide—skin cancer	0.000458	0.00109	CcSEcCtD
Zaleplon—Anxiety—Temozolomide—skin cancer	0.000457	0.00108	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000455	0.00108	CcSEcCtD
Zaleplon—Discomfort—Temozolomide—skin cancer	0.000453	0.00107	CcSEcCtD
Zaleplon—Decreased appetite—Bleomycin—skin cancer	0.000453	0.00107	CcSEcCtD
Zaleplon—Neuropathy peripheral—Docetaxel—skin cancer	0.000449	0.00107	CcSEcCtD
Zaleplon—Dry mouth—Temozolomide—skin cancer	0.000448	0.00106	CcSEcCtD
Zaleplon—Stomatitis—Docetaxel—skin cancer	0.000447	0.00106	CcSEcCtD
Zaleplon—Pain—Bleomycin—skin cancer	0.000446	0.00106	CcSEcCtD
Zaleplon—Conjunctivitis—Docetaxel—skin cancer	0.000445	0.00106	CcSEcCtD
Zaleplon—Confusional state—Temozolomide—skin cancer	0.000443	0.00105	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000443	0.00105	CcSEcCtD
Zaleplon—Oedema—Temozolomide—skin cancer	0.000439	0.00104	CcSEcCtD
Zaleplon—Anaphylactic shock—Temozolomide—skin cancer	0.000439	0.00104	CcSEcCtD
Zaleplon—Nausea—Imiquimod—skin cancer	0.000436	0.00103	CcSEcCtD
Zaleplon—Hepatobiliary disease—Docetaxel—skin cancer	0.000433	0.00103	CcSEcCtD
Zaleplon—Epistaxis—Docetaxel—skin cancer	0.000432	0.00102	CcSEcCtD
Zaleplon—Nervous system disorder—Temozolomide—skin cancer	0.000431	0.00102	CcSEcCtD
Zaleplon—Feeling abnormal—Bleomycin—skin cancer	0.000429	0.00102	CcSEcCtD
Zaleplon—Skin disorder—Temozolomide—skin cancer	0.000427	0.00101	CcSEcCtD
Zaleplon—Hyperhidrosis—Temozolomide—skin cancer	0.000425	0.00101	CcSEcCtD
Zaleplon—Myalgia—Fluorouracil—skin cancer	0.000422	0.001	CcSEcCtD
Zaleplon—Chest pain—Fluorouracil—skin cancer	0.000422	0.001	CcSEcCtD
Zaleplon—Decreased appetite—Dactinomycin—skin cancer	0.000422	0.001	CcSEcCtD
Zaleplon—Anorexia—Temozolomide—skin cancer	0.000419	0.000993	CcSEcCtD
Zaleplon—Discomfort—Fluorouracil—skin cancer	0.000417	0.00099	CcSEcCtD
Zaleplon—Pain—Dactinomycin—skin cancer	0.000416	0.000985	CcSEcCtD
Zaleplon—Urticaria—Bleomycin—skin cancer	0.000414	0.000981	CcSEcCtD
Zaleplon—Body temperature increased—Bleomycin—skin cancer	0.000412	0.000977	CcSEcCtD
Zaleplon—Hypoaesthesia—Docetaxel—skin cancer	0.000409	0.000971	CcSEcCtD
Zaleplon—Confusional state—Fluorouracil—skin cancer	0.000408	0.000968	CcSEcCtD
Zaleplon—Oedema peripheral—Docetaxel—skin cancer	0.000405	0.000961	CcSEcCtD
Zaleplon—Anaphylactic shock—Fluorouracil—skin cancer	0.000405	0.00096	CcSEcCtD
Zaleplon—Oedema—Fluorouracil—skin cancer	0.000405	0.00096	CcSEcCtD
Zaleplon—CYP3A4—female reproductive system—skin cancer	0.000404	0.0109	CbGeAlD
Zaleplon—Feeling abnormal—Dactinomycin—skin cancer	0.0004	0.000949	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Temozolomide—skin cancer	0.0004	0.000949	CcSEcCtD
Zaleplon—Insomnia—Temozolomide—skin cancer	0.000397	0.000943	CcSEcCtD
Zaleplon—Gastrointestinal pain—Dactinomycin—skin cancer	0.000397	0.000942	CcSEcCtD
Zaleplon—Nervous system disorder—Fluorouracil—skin cancer	0.000397	0.000942	CcSEcCtD
Zaleplon—Visual impairment—Docetaxel—skin cancer	0.000396	0.00094	CcSEcCtD
Zaleplon—Tachycardia—Fluorouracil—skin cancer	0.000395	0.000937	CcSEcCtD
Zaleplon—Paraesthesia—Temozolomide—skin cancer	0.000395	0.000936	CcSEcCtD
Zaleplon—Dyspnoea—Temozolomide—skin cancer	0.000392	0.000929	CcSEcCtD
Zaleplon—Somnolence—Temozolomide—skin cancer	0.000391	0.000926	CcSEcCtD
Zaleplon—Dyspepsia—Temozolomide—skin cancer	0.000387	0.000917	CcSEcCtD
Zaleplon—Anorexia—Fluorouracil—skin cancer	0.000386	0.000915	CcSEcCtD
Zaleplon—Eye disorder—Docetaxel—skin cancer	0.000384	0.000912	CcSEcCtD
Zaleplon—Body temperature increased—Dactinomycin—skin cancer	0.000384	0.000911	CcSEcCtD
Zaleplon—Abdominal pain—Dactinomycin—skin cancer	0.000384	0.000911	CcSEcCtD
Zaleplon—Decreased appetite—Temozolomide—skin cancer	0.000382	0.000906	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Temozolomide—skin cancer	0.000379	0.0009	CcSEcCtD
Zaleplon—Hypotension—Fluorouracil—skin cancer	0.000378	0.000897	CcSEcCtD
Zaleplon—Pain—Temozolomide—skin cancer	0.000376	0.000891	CcSEcCtD
Zaleplon—Constipation—Temozolomide—skin cancer	0.000376	0.000891	CcSEcCtD
Zaleplon—Asthenia—Bleomycin—skin cancer	0.000374	0.000886	CcSEcCtD
Zaleplon—Immune system disorder—Docetaxel—skin cancer	0.000372	0.000881	CcSEcCtD
Zaleplon—Chills—Docetaxel—skin cancer	0.000369	0.000875	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000369	0.000875	CcSEcCtD
Zaleplon—Pruritus—Bleomycin—skin cancer	0.000369	0.000874	CcSEcCtD
Zaleplon—Insomnia—Fluorouracil—skin cancer	0.000366	0.000868	CcSEcCtD
Zaleplon—Paraesthesia—Fluorouracil—skin cancer	0.000364	0.000862	CcSEcCtD
Zaleplon—Alopecia—Docetaxel—skin cancer	0.000364	0.000862	CcSEcCtD
Zaleplon—Feeling abnormal—Temozolomide—skin cancer	0.000362	0.000859	CcSEcCtD
Zaleplon—Dyspnoea—Fluorouracil—skin cancer	0.000361	0.000856	CcSEcCtD
Zaleplon—Mental disorder—Docetaxel—skin cancer	0.00036	0.000855	CcSEcCtD
Zaleplon—Somnolence—Fluorouracil—skin cancer	0.00036	0.000854	CcSEcCtD
Zaleplon—Gastrointestinal pain—Temozolomide—skin cancer	0.000359	0.000852	CcSEcCtD
Zaleplon—Malnutrition—Docetaxel—skin cancer	0.000358	0.000849	CcSEcCtD
Zaleplon—Dyspepsia—Fluorouracil—skin cancer	0.000356	0.000845	CcSEcCtD
Zaleplon—Decreased appetite—Fluorouracil—skin cancer	0.000352	0.000835	CcSEcCtD
Zaleplon—Dysgeusia—Docetaxel—skin cancer	0.000351	0.000832	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Fluorouracil—skin cancer	0.00035	0.000829	CcSEcCtD
Zaleplon—Urticaria—Temozolomide—skin cancer	0.000349	0.000828	CcSEcCtD
Zaleplon—Asthenia—Dactinomycin—skin cancer	0.000349	0.000827	CcSEcCtD
Zaleplon—Abdominal pain—Temozolomide—skin cancer	0.000347	0.000824	CcSEcCtD
Zaleplon—Body temperature increased—Temozolomide—skin cancer	0.000347	0.000824	CcSEcCtD
Zaleplon—Back pain—Docetaxel—skin cancer	0.000346	0.000821	CcSEcCtD
Zaleplon—Pain—Fluorouracil—skin cancer	0.000346	0.000821	CcSEcCtD
Zaleplon—Feeling abnormal—Fluorouracil—skin cancer	0.000334	0.000791	CcSEcCtD
Zaleplon—Anaemia—Docetaxel—skin cancer	0.000331	0.000785	CcSEcCtD
Zaleplon—Rash—Bleomycin—skin cancer	0.000329	0.000779	CcSEcCtD
Zaleplon—Dermatitis—Bleomycin—skin cancer	0.000328	0.000778	CcSEcCtD
Zaleplon—Urticaria—Fluorouracil—skin cancer	0.000322	0.000763	CcSEcCtD
Zaleplon—Syncope—Docetaxel—skin cancer	0.000321	0.000761	CcSEcCtD
Zaleplon—Body temperature increased—Fluorouracil—skin cancer	0.00032	0.000759	CcSEcCtD
Zaleplon—Palpitations—Docetaxel—skin cancer	0.000316	0.00075	CcSEcCtD
Zaleplon—Asthenia—Temozolomide—skin cancer	0.000315	0.000748	CcSEcCtD
Zaleplon—Loss of consciousness—Docetaxel—skin cancer	0.000315	0.000746	CcSEcCtD
Zaleplon—Pruritus—Temozolomide—skin cancer	0.000311	0.000737	CcSEcCtD
Zaleplon—Nausea—Bleomycin—skin cancer	0.000309	0.000734	CcSEcCtD
Zaleplon—Hypertension—Docetaxel—skin cancer	0.000309	0.000733	CcSEcCtD
Zaleplon—Rash—Dactinomycin—skin cancer	0.000306	0.000726	CcSEcCtD
Zaleplon—Arthralgia—Docetaxel—skin cancer	0.000305	0.000723	CcSEcCtD
Zaleplon—Chest pain—Docetaxel—skin cancer	0.000305	0.000723	CcSEcCtD
Zaleplon—Myalgia—Docetaxel—skin cancer	0.000305	0.000723	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000303	0.000718	CcSEcCtD
Zaleplon—Dry mouth—Docetaxel—skin cancer	0.000298	0.000707	CcSEcCtD
Zaleplon—Confusional state—Docetaxel—skin cancer	0.000295	0.000699	CcSEcCtD
Zaleplon—Anaphylactic shock—Docetaxel—skin cancer	0.000292	0.000693	CcSEcCtD
Zaleplon—Oedema—Docetaxel—skin cancer	0.000292	0.000693	CcSEcCtD
Zaleplon—Dizziness—Temozolomide—skin cancer	0.000291	0.000689	CcSEcCtD
Zaleplon—Nausea—Dactinomycin—skin cancer	0.000289	0.000684	CcSEcCtD
Zaleplon—Shock—Docetaxel—skin cancer	0.000288	0.000682	CcSEcCtD
Zaleplon—Nervous system disorder—Docetaxel—skin cancer	0.000287	0.00068	CcSEcCtD
Zaleplon—Pruritus—Fluorouracil—skin cancer	0.000286	0.000679	CcSEcCtD
Zaleplon—Tachycardia—Docetaxel—skin cancer	0.000285	0.000676	CcSEcCtD
Zaleplon—Skin disorder—Docetaxel—skin cancer	0.000284	0.000673	CcSEcCtD
Zaleplon—Anorexia—Docetaxel—skin cancer	0.000279	0.000661	CcSEcCtD
Zaleplon—Rash—Temozolomide—skin cancer	0.000277	0.000657	CcSEcCtD
Zaleplon—Dermatitis—Temozolomide—skin cancer	0.000277	0.000656	CcSEcCtD
Zaleplon—Headache—Temozolomide—skin cancer	0.000275	0.000653	CcSEcCtD
Zaleplon—Hypotension—Docetaxel—skin cancer	0.000273	0.000648	CcSEcCtD
Zaleplon—Dizziness—Fluorouracil—skin cancer	0.000268	0.000635	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000266	0.000631	CcSEcCtD
Zaleplon—Insomnia—Docetaxel—skin cancer	0.000264	0.000627	CcSEcCtD
Zaleplon—Paraesthesia—Docetaxel—skin cancer	0.000262	0.000622	CcSEcCtD
Zaleplon—Nausea—Temozolomide—skin cancer	0.000261	0.000619	CcSEcCtD
Zaleplon—Dyspnoea—Docetaxel—skin cancer	0.000261	0.000618	CcSEcCtD
Zaleplon—Somnolence—Docetaxel—skin cancer	0.00026	0.000616	CcSEcCtD
Zaleplon—Dyspepsia—Docetaxel—skin cancer	0.000257	0.00061	CcSEcCtD
Zaleplon—Rash—Fluorouracil—skin cancer	0.000255	0.000605	CcSEcCtD
Zaleplon—Dermatitis—Fluorouracil—skin cancer	0.000255	0.000605	CcSEcCtD
Zaleplon—Decreased appetite—Docetaxel—skin cancer	0.000254	0.000602	CcSEcCtD
Zaleplon—Headache—Fluorouracil—skin cancer	0.000254	0.000602	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Docetaxel—skin cancer	0.000252	0.000598	CcSEcCtD
Zaleplon—Pain—Docetaxel—skin cancer	0.00025	0.000593	CcSEcCtD
Zaleplon—Constipation—Docetaxel—skin cancer	0.00025	0.000593	CcSEcCtD
Zaleplon—Feeling abnormal—Docetaxel—skin cancer	0.000241	0.000571	CcSEcCtD
Zaleplon—Nausea—Fluorouracil—skin cancer	0.000241	0.00057	CcSEcCtD
Zaleplon—Gastrointestinal pain—Docetaxel—skin cancer	0.000239	0.000567	CcSEcCtD
Zaleplon—Abdominal pain—Docetaxel—skin cancer	0.000231	0.000548	CcSEcCtD
Zaleplon—Body temperature increased—Docetaxel—skin cancer	0.000231	0.000548	CcSEcCtD
Zaleplon—Asthenia—Docetaxel—skin cancer	0.00021	0.000497	CcSEcCtD
Zaleplon—Pruritus—Docetaxel—skin cancer	0.000207	0.00049	CcSEcCtD
Zaleplon—Dizziness—Docetaxel—skin cancer	0.000193	0.000458	CcSEcCtD
Zaleplon—Rash—Docetaxel—skin cancer	0.000184	0.000437	CcSEcCtD
Zaleplon—Dermatitis—Docetaxel—skin cancer	0.000184	0.000437	CcSEcCtD
Zaleplon—Headache—Docetaxel—skin cancer	0.000183	0.000434	CcSEcCtD
Zaleplon—Nausea—Docetaxel—skin cancer	0.000174	0.000412	CcSEcCtD
